Search details
1.
Phenotypes of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatocellular Carcinoma.
Clin Gastroenterol Hepatol
; 2024 Apr 10.
Article
in English
| MEDLINE | ID: mdl-38604295
2.
Outcome of patients with HCC and liver dysfunction under immunotherapy: a systematic review and meta-analysis.
Hepatology
; 77(4): 1139-1149, 2023 04 01.
Article
in English
| MEDLINE | ID: mdl-36632997
3.
Liver cancer risk after HCV cure in patients with advanced liver disease without non-characterized nodules.
J Hepatol
; 76(4): 874-882, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-34856322
4.
Outcome of liver cancer patients with SARS-CoV-2 infection: An International, Multicentre, Cohort Study.
Liver Int
; 42(8): 1891-1901, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35608939
5.
The tireless search to improve the prognostic assessment of intrahepatic cholangiocarcinoma: An urgent need.
Liver Int
; 41(2): 252-254, 2021 02.
Article
in English
| MEDLINE | ID: mdl-33464725
6.
Risk of Treatment Failure and Death after Ablation in Hepatocellular Carcinoma Patients-A Multiparametric Prediction.
Cancers (Basel)
; 15(13)2023 Jun 21.
Article
in English
| MEDLINE | ID: mdl-37444380
7.
Prevalence and Risk Factors of MASLD and Liver Fibrosis amongst the Penitentiary Population in Catalonia: The PRISONAFLD Study.
J Clin Med
; 12(23)2023 Nov 24.
Article
in English
| MEDLINE | ID: mdl-38068330
8.
Portopulmonary Hypertension: An Updated Review.
Transplant Direct
; 9(8): e1517, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-37492078
9.
Survival and adverse events of elderly patients treated with sorafenib for hepatocellular carcinoma.
Front Oncol
; 12: 829483, 2022.
Article
in English
| MEDLINE | ID: mdl-35982971
10.
Current pharmacological treatment of hepatocellular carcinoma.
Curr Opin Pharmacol
; 60: 141-148, 2021 10.
Article
in English
| MEDLINE | ID: mdl-34418875
11.
Activated Lymphocytes and Increased Risk of Dermatologic Adverse Events during Sorafenib Therapy for Hepatocellular Carcinoma.
Cancers (Basel)
; 13(3)2021 Jan 23.
Article
in English
| MEDLINE | ID: mdl-33498698
12.
Early diarrhoea under sorafenib as a marker to consider the early migration to second-line drugs.
United European Gastroenterol J
; 9(6): 655-661, 2021 07.
Article
in English
| MEDLINE | ID: mdl-34228394
13.
Assessing the impact of COVID-19 on liver cancer management (CERO-19).
JHEP Rep
; 3(3): 100260, 2021 Jun.
Article
in English
| MEDLINE | ID: mdl-33644725
14.
Advancing towards accurate phenotyping based on metabolic and fibrosis risk in metabolic-dysfunction associated steatotic liver disease: one step closer to personalized care.
Hepatobiliary Surg Nutr
; 13(1): 128-131, 2024 Feb 01.
Article
in English
| MEDLINE | ID: mdl-38322230
15.
[Portopulmonary hypertension: Updated review]. / Hipertensión portopulmonar: Revisión actualizada.
Arch Cardiol Mex
; 88(1): 25-38, 2018.
Article
in Spanish
| MEDLINE | ID: mdl-27986561
16.
Hipertensión portopulmonar: Revisión actualizada / Portopulmonary hypertension: Updated review
Arch. cardiol. Méx
; 88(1): 25-38, ene.-mar. 2018. tab
Article
in Spanish
| LILACS | ID: biblio-1054985
17.
Platelet aggregation in whole blood, a new approach for understanding the antiplatelet effect of N-(3-hydroxy-1,3,5(10)-estratrien-17b-yl) butylamine (buame).
Proc West Pharmacol Soc
; 52: 50-3, 2009.
Article
in English
| MEDLINE | ID: mdl-22128422
Results
1 -
17
de 17
1
Next >
>>